Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

"I would say to anyone, if standard treatment isn’t working for you, then ask about clinical trials. I’m so glad I did." ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

A new tooth-regrowing drug has finally entered human trials after months of waiting and promising clinical trials on mice and ...

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...

Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...

Researchers in 2024 made unique and important discoveries that promise to help individuals suffering from addiction and their ...

Apollomics Inc., a late-stage clinical biopharmaceutical company, said its leukemia drug failed to pass trials in China, a ...

A Drug Enforcement Administration special agent candidate lacked evidence that discrimination based on the combination of her ...

Earlier this month, the US Food and Drug Administration (FDA) issued new draft guidance regarding their accelerated approval pathway for new drugs ...

Susan Sharfstein, a professor at UAlbany's College of Nanotechnology, Science and Engineering, partners with DeepSeq.AI on a ...

Novo shares lost nearly a fifth of their value after an experimental combination treatment called cagrisema fell short of the ...